Benzinga's Top Initiations By: Benzinga via Benzinga June 01, 2015 at 10:17 AM EDT Analysts at Stifel Nicolaus initiated coverage on CoLucid Pharmaceuticals Inc (NASDAQ: CLCD) with a Buy rating. The target price for ... Read More >> Related Stocks: Adaptimmune Ther ADR Affimed Ord Shs Atyr Pharma Inc Collegium Pharma Fate Therapeutics PetroChina Prothena Corp Tallgrass Energy Gp LP